Suppr超能文献

[具体植物名称]提取物及成分对人肝脏葡萄糖醛酸化活性的抑制作用。 (注:原文中“ , , , and ”部分未明确具体内容,这里用“[具体植物名称]”代替,需根据实际情况补充完整)

Inhibitory Effects of , , , and Extracts and Constituents on Human Liver Glucuronidation Activity.

作者信息

Husni Zulhilmi, Ismail Sabariah, Zulkiffli Mohd Halimhilmi, Afandi Atiqah, Haron Munirah

机构信息

Centre for Drug Research, Universiti Sains Malaysia, Pulau Pinang, Malaysia.

出版信息

Pharmacogn Mag. 2017 Jul;13(Suppl 2):S236-S243. doi: 10.4103/pm.pm_299_16. Epub 2017 Jul 11.

Abstract

BACKGROUND

, , and are commonly consumed as herbal medicines. However their effects on human liver glucuronidation activity are not yet evaluated.

OBJECTIVE

In this study, we evaluate the inhibitory Effects of Andrographis paniculata, Gynura procumbens, Ficus deltoidea and Curcuma xanthorrhiza extracts and their constituents on human liver glucuronidation activity.

MATERIALS AND METHODS

Herbal extracts (aqueous, methanolic and ethanolic extracts) and their constituents were incubated with human liver microsomes with the addition of UDPGA to initiate the reaction. Working concentrations of herbal extracts and their constituents ranged from 10 μg/mL to 1000 μg/mL and 10 μM to 300 μM respectively. IC50 was determined by monitoring the decrement of glucuronidation activity with the increment of herbal extracts or phytochemical constituent's concentrations.

RESULTS

All herbal extracts inhibited human liver glucuronidation activity in range of 34.69 μg/mL to 398.10 μg/mL whereas for the constituents, only xanthorrhizol and curcumin (constituents of ) inhibited human liver glucuronidation activity with IC50 of 538.50 and 32.26 μM respectively.

CONCLUSION

In the present study, we have proved the capabilities of , , and to interfere with glucuronidation process in human liver microsomes.

SUMMARY

This study documented the capabilities of , , and to inhibit human liver glucuronidation activity which may affect the metabolism of therapeutic drugs or hazardous toxicants that follow the same glucuronidation pathway. UGT: Uridine 5'-diphospho-glucuronosyltransferase; 4-MU: 4-methylumbelliferone; IC50: Half Maximal Inhibitory Concentration; Km: Michaelis constant; Vmax: Maximum velocity.

摘要

背景

穿心莲、白凤菜、三角叶榕和郁金通常作为草药使用。然而,它们对人肝脏葡萄糖醛酸化活性的影响尚未得到评估。

目的

在本研究中,我们评估了穿心莲、白凤菜、三角叶榕和郁金提取物及其成分对人肝脏葡萄糖醛酸化活性的抑制作用。

材料与方法

将草药提取物(水提取物、甲醇提取物和乙醇提取物)及其成分与人肝微粒体一起孵育,并添加尿苷二磷酸葡萄糖醛酸(UDPGA)以启动反应。草药提取物及其成分的工作浓度分别为10μg/mL至1000μg/mL和10μM至300μM。通过监测随着草药提取物或植物化学成分浓度增加葡萄糖醛酸化活性的降低来确定半数最大抑制浓度(IC50)。

结果

所有草药提取物在34.69μg/mL至398.10μg/mL范围内抑制人肝脏葡萄糖醛酸化活性,而对于其成分,只有莪术烯醇和姜黄素(郁金的成分)抑制人肝脏葡萄糖醛酸化活性,IC50分别为538.50和32.26μM。

结论

在本研究中,我们证明了穿心莲、白凤菜、三角叶榕和郁金干扰人肝微粒体中葡萄糖醛酸化过程的能力。

总结

本研究记录了穿心莲、白凤菜、三角叶榕和郁金抑制人肝脏葡萄糖醛酸化活性的能力,这可能会影响遵循相同葡萄糖醛酸化途径的治疗药物或有害毒物的代谢。UGT:尿苷5'-二磷酸葡萄糖醛酸基转移酶;4-MU:4-甲基伞形酮;IC50:半数最大抑制浓度;Km:米氏常数;Vmax:最大速度。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3105/5538160/7c50dec6f939/PM-13-236-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验